Clinical Trial Update: On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating UTAA09 injection for recurrent or refractory B-cell non-Hodgkin's lymphoma; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• UTAA09

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Recurrent or Refractory B-cell Non Hodgkin's Lymphoma | Phase 1 | Status: RECRUITING